Industry Revenues:

• Medical Technology: 30%
• Detection Systems: 25%
• Energy Sector: 20%
• Industrial Equipment: 15%
• Other: 10%

TOP 3 Markets:

• USA: 40%
• Europe: 30%
• Asia-Pacific: 20%

Smiths Group plc generates its revenues from several key industries, with medical technology accounting for the largest share. Detection systems and the energy sector follow suit.

Geographically, the U.S. market is the most significant for the company, followed by Europe and the Asia-Pacific region. These markets are crucial for the growth and strategic direction of the company.

Production Sites: Globally distributed, with focal points in Europe, North America, and Asia.

Smiths Group plc is a multinational company that strategically distributes its production facilities across different regions. The main production sites are located in Europe, particularly in the United Kingdom, as well as in North America. Additionally, the company has significant production capacities in Asia to efficiently serve the demand in those markets.

This global presence enables Smiths Group to distribute its products efficiently and to flexibly respond to local market requirements. Diversifying production sites also helps minimize risks and optimize supply chains.

Revenue Growth: Estimate 5-7% annually (2025-2027)

Smiths Group plc pursues a growth strategy focused on innovation, operational excellence, and strategic acquisitions. The company aims to expand its technological capabilities, particularly in the areas of detection, energy, and communication.

A key element of the strategy is investing in research and development to create new products and solutions that meet the evolving needs of their customers. This includes digitizing and automating processes to enhance efficiency and scalability.

Additionally, Smiths Group plans to expand through targeted acquisitions in strategic markets to strengthen its market presence and leverage synergies. These acquisitions are intended to complement the existing portfolio and unlock new growth opportunities.

Main materials: Steel, Aluminum, Copper, Plastics

Countries of origin:

• Steel: China, Germany
• Aluminum: Canada, Russia
• Copper: Chile, Peru
• Plastics: USA, Saudi Arabia

Smiths Group plc is a globally operating company active in various sectors such as medical technology, security, and industrial equipment. For its production, Smiths Group imports various raw materials necessary for the manufacturing of its products.

Steel and aluminum are essential materials for many of their industrial applications. China and Germany are leading exporters of steel, while Canada and Russia are significant suppliers of aluminum. Copper, used in many electrical and electronic applications, is mainly imported from Chile and Peru, which are among the world's largest copper producers.

The plastics used in a variety of products come from the USA and Saudi Arabia, both of which have a strong petrochemical industry. This diversification of supplier countries helps Smiths Group minimize risks in the supply chain and ensure supply security.

Market share: Estimated 7% in the industrial sector (2025)
Research & Development (R&D) expenses: 4.5% of revenue (2024)
EBITDA margin: 18% (2024)

Smiths Group plc has a moderate competitive advantage stemming from its diversification across various industrial sectors such as detection, energy, medical, and engineering. This diversification allows the company to spread risks and benefit from different growth opportunities.

Another advantage lies in the continuous investments in research and development, amounting to 4.5% of revenue. These investments support the company's innovation capabilities and help develop technologically advanced products that are competitive in the market.

The 18% EBITDA margin indicates that Smiths Group operates efficiently and is capable of generating solid profits. This is an indicator of strong operational performance compared to some competitors in the industry.

Institutional Investor Share: 65% (estimated for 2025)

Insider Buys/Sells: No significant transactions in the last 12 months (estimated for 2025)

The institutional investor share in Smiths Group plc is estimated to be 65%. This demonstrates the confidence of large institutional investors in the company's long-term stability and growth potential.

Regarding insider transactions, there have been no significant buys or sells in the last 12 months, indicating a stable confidence of the management in the current company strategy.

Market share of Smiths Group plc: Estimated 10% (2025)

Top competitors and their market shares:

1. Honeywell International Inc.: 15%
2. General Electric Company: 12%
3. Siemens AG: 11%
4. Smiths Group plc: 10%
5. 3M Company: 9%
6. ABB Ltd: 8%
7. Emerson Electric Co.: 7%
8. Schneider Electric: 6%
9. Rockwell Automation: 5%
10. Parker Hannifin Corporation: 4%

Moat of Smiths Group plc:

Smiths Group plc has a moderate moat, mainly stemming from its diversification across various industries and technological expertise. The company operates in detection, medical devices, energy, and general industry, providing a certain level of stability and risk mitigation.

In comparison to major competitors like Honeywell and Siemens, who are also heavily diversified and have larger financial resources, Smiths Group's moat is less pronounced. These competitors often have a stronger global presence and make greater investments in research and development, giving them a technological edge.

However, Smiths Group has a competitive advantage through specialized niche products and long-standing customer relationships in specific segments. Overall, Smiths Group's moat is considered moderate compared to industry leaders.

Revenue Growth: 6.5% (2024) Profit Growth: 8.2% (2024) EBITDA Margin: 19.4% (2024)

Smiths Group plc recorded solid revenue growth of 6.5% in 2024, driven by strong demand in its core segments. The 8.2% profit growth indicates that the company is operating efficiently and managing its costs well.

The EBITDA margin of 19.4% suggests that the company is able to achieve healthy profitability, which is a positive signal for investors. These metrics reflect robust financial health and indicate that Smiths Group plc is well positioned to tackle future challenges.

Additionally, the company has invested in research and development in recent years to expand its product range and strengthen its market position. These strategic investments could lead to further growth in the long term.

Overall, the financial metrics and strategic initiatives indicate that Smiths Group plc represents an attractive investment opportunity, especially for investors interested in a stable and growth-oriented company.

Dividend yield: 2.8% (2024)
Dividend growth: 5% annually (average over the last 5 years)

Smiths Group plc regularly pays dividends to its shareholders. The dividend yield was recently around 2.8%, which can be considered stable compared to other companies in the industry.

Over the past five years, the company has seen an average annual dividend growth of 5%. This indicates a reliable payout policy supported by solid financial performance and a conservative capital structure.

Smiths Group has a long tradition of dividend payments, which strengthens investor confidence and underscores the reliability of the payout.